Please login to the form below
Clinical Research
This page shows the latest Clinical Research news and features for those working in and with pharma, biotech and healthcare.
Merck ends its COVID-19 vaccine programme after disappointing early trial results
On a more positive note, Merck will continue to advance clinical programmes for two novel therapeutics targeting SARS-CoV-2, the virus which causes COVID-19. ... The antiviral agent is already being evaluated in phase 2/3 clinical trials in hospital and
Latest news
-
Moderna’s COVID-19 vaccine appears effective against UK and South Africa variants
However, vaccine has a six-fold reduction in neutralising antibodies against SA strain
-
UK study finds antibiotics azithromycin and doxycycline ineffective against COVID-19
Based on the interim incomplete data, investigators found that both the estimated clinical benefit in the recovery time and hospitalisation rate was ‘small’ for doxycycline – less than a one-day benefit ... In England, clinical guidance currently
-
AZ refutes reports suggesting its COVID-19 vaccine is less effective in the elderly
Regarding the German media reports, an Oxford University spokesperson commented: “The results of the clinical trials have already been published transparently in five peer-reviewed scientific publications showing similar immune responses
-
Lilly’s antibody bamlanivimab cuts COVID-19 risk by up to 80%
The EUA was supported by an interim analysis conducted on Lilly’s BLAZE-1 clinical trial, in which bamlanivimab cleared SARS-CoV-2 by day 11 in most patients with ... reviewed clinical journal.
-
Pfizer/BioNTech's COVID-19 vaccine found to be effective against UK virus variant
Further research will confirm the early findings of this study, the researchers added.
More from news
Approximately 3 fully matching, plus 2,307 partially matching documents found.
Latest Intelligence
-
Sourcing R&D innovation: why pharma companies need to evolve their business models
targeting specialty therapeutic areas and the pace of innovation in clinical research and drug development to remain competitive and ensure success in the years ahead. ... Also, on the execution side of R&D, many companies outsource development to
-
2021: the year of decentralisation in drug development
Improve patient-centricity, trial quality and outcomes with digital health. COVID-19 highlighted the lack of diversity in clinical research, as certain segments of the population, such as older adults, pregnant ... For example, assuming a clinical
-
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
both clinical outcomes and quality of life.
-
Treatment and prevention of cardiovascular disease
In this context, the recent resurgence in omega-3 fatty acid research and the clinical data that has been produced provide an avenue for the development of such multifaceted therapies. ... Epeleuton. is the company’s first next generation synthetic
-
After years of potential, cell and gene therapy is ready for the pharmaceutical mainstream
But with continued innovation – much of it coming from biotech companies – we have now reached the stage where products once on the periphery of pharmaceutical research are being sanctioned with FDA ... Mark Brewer is Research Director, Life Sciences
More from intelligence
Approximately 2 fully matching, plus 160 partially matching documents found.
Latest appointments
-
Azafaros expands executive team with three senior hires
Also joining the senior team is Ruben Giorgino (pictured above), who has been appointed head of clinical research and development. ... He joins from Helsinn Group, where he held the position of global head of clinical research and development.
-
NICE looks internally for new chief executive
Originally training in medicine, Leng went on to work on clinical trials and epidemiological research as well as a consultant in public health medicine. ... During her time at NICE, she held responsibility for setting up and running the clinical
-
New hires at Crescendo, Healx and Galecto
late phase clinical trials. Before that, he was clinical research physician at Chugai Pharma Europe, where he led clinical development for a bispecific T-cell engaging antibody programme and other early ... Prior to eTheRNA, Lindmark served as global VP
-
New hires at Bristol-Myers Squibb, Acceleron and FerGene
He has been appointed to the newly created role of head of research and development at the company, and brings almost three decades of global clinical and regulatory experience to Acceleron. ... He began his career at Marion Merrell Dow, and continued as
-
New hires at Abbott, Kite and Arrakis Therapeutics
Also joining Kite is Ken Takeshita, who has been appointed as global head of clinical development. ... He joins Kit from Sorrento Therapeutics, where is worked as senior vice president, clinical research, and held responsibility for clinical development
More from appointments
Approximately 0 fully matching, plus 172 partially matching documents found.
Latest from PMHub
-
#DemandDiversity: New research on COVID-19 clinical trial perceptions within minorities and high-risk populations
taking part in clinical research. ... Our previous research in this area unearthed shocking but not surprising findings, with immense mistrust in healthcare and clinical trials shown by people from ethnic minority backgrounds.
-
3 reasons why clinical trials will thrive in 2021
With greater awareness of the importance of healthcare, comes a new spotlight on clinical trials. ... Further, the health inequalities that were presented by the pandemic have shed a light on the lack of diverse representation in clinical trials.
-
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. ... A brilliant video from the Center for Information and Study on Clinical
-
What NORD’s RareInsights® 30-year comparative analysis means to us and our clients at OPEN Health
NORD rightfully points out that having a diagnosis (including genetic variations) opens up better support and access to clinical research. Accurate and early diagnosis, therefore remains the fundamental factor in achieving ... It is welcome to see a
-
New from the PhRMA: Diversity in clinical trials principles summarised
In November 2020, PhRMA announced the first-ever, industry-wide principles on clinical trial diversity. ... The policies should be specifically focused on enhancing diversity of clinical trial populations.
More from PMHub
Approximately 7 fully matching, plus 217 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Healthcare Senior Account Manager
-
Competitive
-
Healthcare Lead Copywriter
-
Competitive
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
-
Medical Editor
-
Competitive
-
Healthcare Account Director
-
Competitive
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
- Moderna cooperating with investigation into possible COVID-19 vaccine allergic reactions
- Sanofi, GSK delay COVID-19 vaccine trial after underwhelming results in elderly participants
- New study identifies drugs that are safe to use in COVID-19 treatment
- BMS gains FDA approval for second Opdivo combo in kidney cancer
- GSK’s PD-1 inhibitor dostarlimab shows updated promise in dMMR solid tumours
- Pfizer introduces new logo in a ‘shift from commerce to science’
- Moderna’s COVID-19 vaccine appears effective against UK and South Africa variants
- AZ refutes reports suggesting its COVID-19 vaccine is less effective in the elderly
- UK study finds antibiotics azithromycin and doxycycline ineffective against COVID-19
- Merck ends its COVID-19 vaccine programme after disappointing early trial results
- Wilmington Healthcare appoints new Head of Digital
- A happier new year?
PMHub
Page & Page and Partners
For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...
Latest intelligence
- An EU emergency health fund to limit the impact of future crises
- Leading finance experts propose an Emergency Health Financing Facility to limit the impact of future crises on the EU...
- Mistrust in medical research: a patient perspective
- The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
- Real-world evidence: breaking boundaries in rare disease
- Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
Quick links
Infographics
